As the endothelial codepletion of NRP1 and NRP2 was found to effectively impair primary lung carcinoma growth and angiogenesis, we proceeded to assess the efficacy of their codepletion in other paradigms of cancer. This evidence concerns the gene NRP2 and lung carcinoma.